(OCUL) - Earnings & Price History

OCUL: - 5.61, $168.23M, -0.15 (-2.60%)

Sector: Healthcare - Industry: Biotechnology

Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies for diseases and conditions of the eye using its proprietary hydrogel platform technology in the United States. It markets ReSure Sealant, a hydrogel-based ophthalmic wound sealant to seal corneal incisions following cataract surgery. The companys lead product includes DEXTENZA, which is in Phase III clinical trial for the treatment of post-surgical ocular inflammation and pain during cataract surgery, as well as for the treatment of allergic conjunctivitis; and in Phase II clinical trial for the treatment of inflammatory dry eye disease. It is also developing OTX-TP, which has completed Phase IIb clinical trial for glaucoma and ocular hypertension. In addition, the company has a pipeline of earlier stage punctum plug product candidates, including OTX-MP, which has complet

Past OCUL reports
Earning DateTimeTitleEPS-e EPS-a ClosePrev CloseOpen Day LowDay High Gap % CFO %Change % Volume
2017-03-10BMO-0.458.478.868.617.968.73-2.82%-1.63%-4.40%1.14M
2016-11-09BMO-0.565.245.325.326.051.53%▲12.78%14.50%994.54K
2016-08-09BMO-0.496.086.116.25.686.351.47%-1.94%-0.49%989.97K
2016-05-10BMO-0.4310.1610.8310.899.6211.40.55%-6.70%-6.19%230.03K
2016-03-10BMO-0.477.948.238.487.798.593.04%-6.37%-3.52%249.37K
2015-11-10-0.388.5510.329.668.469.68-6.40%▲-11.49%-17.15%915.54K
2015-08-10AMC-0.3318.6420.72017.5820.1-3.38%-6.80%-9.95%770.14K
2015-05-15-0.39
2014-11-12BMOOcular Theraptx-0.55-0.481615.8115.6515.0116.02-1.01%▲2.24%1.20%113.30K

Login | Register
Saturday Oct 20, 2018   EST
Enter a Ticker:

Economic Calendar

Existing Home Sales 10:00 AM ET Raphael Bostic speaks on Saturday 11:30 AM ET Raphael Bostic Speaks 12:00 PM ET Robert Kaplan Speaks 12:45 PM ET Baker-Hughes Rig Count 1:00 PM ET 

AAII Sentiment Survey

BULL^ neut ^ BEAR

Chart

index chart
index color
SPY257.6450.500.19%41,867,194

Upgrades/Downgrades